- Lobbying
- Lobbying by Seattle Biomedical Research Institute
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
T.J. Petrizzo | Chief of Staff Congresswoman Jennifer Dunn Legislative Assistant Senator Olympia Snowe Staff Liason Committee on Ways and Means Legislative Assistant Congressman Craig James Legislative Assitant Senator Olympia Snowe |
Phil Bond | DOD - DASD for Legislative Affairs Chief of Staff Congresswoman Jennifer Dunn Chief of Staff Congressman Bob McEwen |
T.J Petrizzo | Chief of Staff Congresswoman Jennifer Dunn |
John Little | Chief of Staff, Senator Martinez |
Chris Fidler | n/a |
Joe Mantilla | n/a |
Tricia Barrentine Guay | n/a |
Justin LeBlanc | n/a |
Omar Franco | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Office of Science & Technology Policy (OSTP)
Type of Issue
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Office of Science & Technology Policy (OSTP)
Type of Issue
Health Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Defense
Health Issues
Amendment
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Health Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Health Issues
Registration
Issue(s) they said they’d lobby about: Federal Funding of bioinformatic resources and technologies.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate